Low Expression LncRNA TUBA4B is a Poor Predictor of Prognosis and Regulates Cell Proliferation in Non-Small Cell Lung Cancer

被引：35

作者：

Chen, Jian ^{[1
]}

Hu, Lijuan ^{[1
]}

Wang, Junjun ^{[1
]}

Zhang, Fan ^{[1
]}

Chen, Jie ^{[2
]}

Xu, Gang ^{[1
]}

Wang, Yumin ^{[1
]}

Pan, Qinshi ^{[1
]}

机构：

[1] Wenzhou Med Univ, Dept Lab Med, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China

[2] Wenzhou Med Univ, Dept Intens Care Unit, Affiliated Hosp 1, Wenzhou 325000, Zhejiang, Peoples R China

来源：

PATHOLOGY & ONCOLOGY RESEARCH | 2017年 / 23卷 / 02期

基金：

中国国家自然科学基金;

关键词：

Non-small cell lung cancer; lncRNAs; TUBA4B; Prognosis; LONG NONCODING RNA; PROSTATE-CANCER; GENE; METASTASIS; SURVIVAL; NSCLC; STATE;

D O I：

10.1007/s12253-016-0089-y

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We aimed to unveil the clinical roles and biological function of lncRNA TUBA4B in on-small cell lung cancer (NSCLC). The relative expression level of TUBA4B was estimated by qPCR in 114 pairs of NSCLC and NT samples and the relation of TUBA4B to clinical data of NSCLC patients was analyzed. We found TUBA4B was lower expressed in NSCLC and five cell lines. The lower expression of TUBA4B was remarkably correlated with advanced TNM stage and lymph node metastasis and served as a predictor for overall survival of NSCLC. After overexpression of TUBA4B, cell proliferation ability of A549 and NCI-H1299 remarkably decreased. Our study ascertained low expression TUBA4B in NSCLC tissue, cell lines and is a poor predictor for prognosis and can regulate cell proliferation in NSCLC.

引用

页码：265 / 270

页数：6

共 50 条

[21] Loss of Bad expression confers poor prognosis in non-small cell lung cancer
Yi Huang
Dan Liu
Bojiang Chen
Jing Zeng
Lei Wang
Shangfu Zhang
Xianming Mo
Weimin Li
Medical Oncology, 2012, 29 : 1648 - 1655
[22] High Expression of PHGDH Predicts Poor Prognosis in Non-Small Cell Lung Cancer
Zhu, Jinhong
Ma, Jianqun
Wang, Xudong
Ma, Tianjiao
Zhang, Shu
Wang, Wei
Zhou, Xiaoyu
Shi, Jiahai
TRANSLATIONAL ONCOLOGY, 2016, 9 (06): : 592 - 599
[23] High expression of MYEOV reflects poor prognosis in non-small cell lung cancer
Zhang, Rui
Ma, Aiqing
GENE, 2021, 770
[24] Loss of Bad expression confers poor prognosis in non-small cell lung cancer
Huang, Yi
Liu, Dan
Chen, Bojiang
Zeng, Jing
Wang, Lei
Zhang, Shangfu
Mo, Xianming
Li, Weimin
MEDICAL ONCOLOGY, 2012, 29 (03) : 1648 - 1655
[25] Low expression of BTN3A3 indicates poor prognosis and promotes cell proliferation, migration and invasion in non-small cell lung cancer
Cheng, Xu
Ma, Tianyu
Yi, Ling
Su, Chongyu
Wang, Xiaojue
Wen, Tao
Wang, Bing
Wang, Yuxuan
Zhang, Hongtao
Liu, Zhidong
ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
[26] LncRNA GHET1 predicts a poor prognosis of the patients with non-small cell lung cancer
Shen, Q-M
Wang, H-Y
Xu, S.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (08) : 2328 - 2333
[27] LINK-A lncRNA is upregulated in metastatic non-small cell lung cancer and is associated with poor prognosis
Liu, Junqiang
Song, Weian
Li, Jun
Li, Xuechang
Zhao, Rongrong
Gong, Taiqian
ONCOLOGY LETTERS, 2019, 18 (03) : 3049 - 3057
[28] AP-4 predicts poor prognosis in non-small cell lung cancer
Gong, Hai
Han, Shaorong
Yao, Hui
Zhao, Hui
Wang, Yanming
MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 336 - 340
[29] Low claudin-6 expression correlates with poor prognosis in patients with non-small cell lung cancer
Wang, Qiang
Zhang, Yan
Zhang, Tao
Han, Zhi-Gang
Shan, Li
ONCOTARGETS AND THERAPY, 2015, 8 : 1971 - 1977
[30] Neutrophil to lymphocyte ratio (NLR) as a predictor of poor prognosis in advanced non-small cell lung cancer
Cherif, Hela
Bacha, Saoussen
Sghaier, Amani
Habibech, Sonia
Racil, Hager
Cheikhrouhou, Sana
Chaouech, Naouel
Chabbou, Abdellatif
Megdiche, Mohamed Lamine
EUROPEAN RESPIRATORY JOURNAL, 2016, 48

← 1 2 3 4 5 →